Related Experiment Videos
No evidence for cholinergic problems in apolipoprotein E knockout and apolipoprotein E4 transgenic mice
F C Bronfman1, I Tesseur, M H Hofker
1Experimental Genetics Group, Center for Human Genetics, Flemish Institute for Biotechnology, K. U. Leuven, Campus Gasthuisberg, B-3000, Leuven, Belgium.
Neuroscience
|June 1, 2000
Summary
The apolipoprotein E4 allele is a major risk factor for Alzheimer's disease. However, this study found no evidence that apolipoprotein E4 directly harms the cholinergic system in mouse brains.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- The apolipoprotein E (APOE) varepsilon4 allele is the primary genetic risk factor for Alzheimer's disease (AD).
- The precise mechanisms by which APOE varepsilon4 contributes to AD pathogenesis remain unclear.
- Cholinergic deficits are a consistent finding in AD brains, but APOE varepsilon4's role in this is unknown.
Purpose of the Study:
- To investigate the impact of apolipoprotein E4 on the cholinergic system in the brain.
- To determine if APOE varepsilon4 influences cholinergic fiber distribution, neuron morphology, or enzymatic activity.
- To assess APOE varepsilon4's effect on the high-affinity choline transporter.
Main Methods:
- Analysis of cholinergic parameters in the brains of apolipoprotein E knockout and human APOE varepsilon4 transgenic mice.
- Assessment of cholinergic fiber distribution, cholinergic neuron count and morphology.
- Measurement of acetylcholinesterase and choline acetyltransferase enzymatic activity.
- Evaluation of [3H]hemicholinium-3 binding to the high-affinity choline transporter.
Main Results:
- No significant differences were observed in cholinergic fiber distribution between APOE varepsilon4 mice and controls.
- The number and morphology of cholinergic neurons were unaffected by APOE varepsilon4 expression.
- Enzymatic activities of acetylcholinesterase and choline acetyltransferase showed no consistent changes.
- High-affinity choline transporter binding parameters were similar across all groups studied.
Conclusions:
- Apolipoprotein E4 does not appear to be inherently detrimental to the mouse cholinergic system.
- These findings suggest that APOE varepsilon4's contribution to Alzheimer's disease may involve pathways independent of direct cholinergic system impairment.